Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Pharmacovigilance and Drug Safety Software Market Report 2026 Featuring Profiles of IQVIA, Oracle Corporation, ArisGlobal, and RXLogix

globenewswire.com
IQV Mentioned as a major industry player in the pharmacovigilance and drug safety software market, which is experiencing significant growth. No specific positive or negative news about IQVIA itself. ORCL Listed as a major industry player in the growing pharmacovigilance and drug safety software market. The article does not provide specific sentiment or news related to Oracle's performance or products. TMO Highlighted for launching CorEvidence, a proprietary cloud-based platform that streamlines pharmacovigilance activities, demonstrating innovation and contribution to industry trends.

Pharmacovigilance and Drug Safety Software Market Report 2026 Featuring Profiles of IQVIA, Oracle Corporation, ArisGlobal, and RXLogix Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Pharmacovigilance and Drug Safety Software Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides vital statistics, including market size, regional shares, competitive landscape, and emerging opportunities, offering a holistic view of the industry's trajectory.

The pharmacovigilance and drug safety software market is witnessing significant growth, expanding from $2.53 billion in 2025 to an anticipated $2.86 billion in 2026, achieving a CAGR of 12.8%. This surge is driven by increasing adverse drug reaction reporting, globalization of clinical trials, stringent safety regulations, growing pharmaceutical production, and expanding post-marketing surveillance needs.

The market shows promising prospects, projected to reach $4.6 billion by 2030 with a CAGR of 12.6%. Contributing factors include advances in AI-driven signal detection, biologics and specialty drug growth, heightened regulatory scrutiny, increased outsourcing of pharmacovigilance services, and the demand for real-time safety analytics. Emerging trends emphasize cloud-based pharmacovigilance platforms, real-world evidence monitoring, and automation in adverse event reporting.

The shift towards personalized medicine is further anticipated to propel market expansion. This healthcare approach tailors treatment to individual genetic profiles and is gaining traction for its superior treatment outcomes, prevention, diagnosis, and cost efficiency. Pharmacovigilance software enhances personalized medicine by integrating pharmacogenomics and real-time data analytics. Notably, the FDA approved 16 new personalized therapies for rare diseases in 2023, significantly up from six in 2022, underscoring the rising demand and its impact on market growth.

Leading companies in the sector are innovating with advanced technologies such as cloud-based data lake platforms. These solutions bolster adverse event detection and regulatory compliance, enhancing patient safety throughout clinical trials and post-marketing phases. For instance, Thermo Fisher Scientific's launch of CorEvidence, a proprietary cloud-based platform, exemplifies this trend by streamlining pharmacovigilance activities with a focus on post-authorization safety studies.

Strategic acquisitions are also shaping the market. In April 2024, Qinecsa acquired Insife ApS, enhancing its pharmacovigilance technology capabilities and strengthening its global market position. This acquisition integrates Insife's cutting-edge safety software into Qinecsa's digital ecosystem.

Major industry players include IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., among others. North America led the market in 2025, while Asia-Pacific is forecasted to grow swiftly.

Reasons to Purchase:

Report Scope

Markets Covered:

Subsegments:

Companies Mentioned: IQVIA, Oracle Corporation, ArisGlobal, RXLogix, and others.

Countries: Includes Australia, Brazil, China, France, Germany, and more.

Regions: Comprehensive coverage of Asia-Pacific, Southeast Asia, Europe, North America, and others.

Time Series: Five years historic data and ten years forecast.

Data and Customization: Market size ratios, GDP proportions, and expenditure per capita, delivered in multiple formats with expert support.

Key Attributes

The companies featured in this Pharmacovigilance and Drug Safety Software market report include:

For more information about this report visit https://www.researchandmarkets.com/r/k8c7hd

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment